Get the Stockscreener App
18.08
3.20%
0.56
After Hours:
18.39
0.31
+1.71%
Phathom Pharmaceuticals Inc stock is traded at $18.08, with a volume of 1.26M.
It is up +3.20% in the last 24 hours and up +9.44% over the past month.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
See More
Previous Close:
$17.52
Open:
$17.53
24h Volume:
1.26M
Relative Volume:
1.45
Market Cap:
$1.21B
Revenue:
-
Net Income/Loss:
$-201.59M
P/E Ratio:
-4.1279
EPS:
-4.38
Net Cash Flow:
$-139.21M
1W Performance:
+1.80%
1M Performance:
+9.44%
6M Performance:
+70.24%
1Y Performance:
+74.35%
1-Day Range:
$17.21
$18.30
1-Week Range:
$17.10
$18.37
52-Week Range:
$6.065
$19.71
Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile
Name
Phathom Pharmaceuticals Inc
Sector
Industry
Phone
(877) 742-8466
Address
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-09-23 | Initiated | H.C. Wainwright | Buy |
| May-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-13-23 | Initiated | Craig Hallum | Buy |
| Oct-21-22 | Initiated | Jefferies | Buy |
| May-06-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-12-21 | Upgrade | Goldman | Sell → Neutral |
| Feb-17-21 | Initiated | BMO Capital Markets | Outperform |
| Feb-02-21 | Initiated | Guggenheim | Buy |
| Jun-26-20 | Downgrade | Goldman | Neutral → Sell |
| Nov-20-19 | Initiated | Evercore ISI | Outperform |
| Nov-19-19 | Initiated | Goldman | Neutral |
| Nov-19-19 | Initiated | Jefferies | Buy |
| Nov-19-19 | Initiated | Needham | Buy |
View All
Phathom Pharmaceuticals Inc Stock (PHAT) Latest News
Phathom Pharmaceuticals Inc (PHAT)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Its Stock Has Paid Off Big Time For Phathom Pharmaceuticals Inc - SETE News
Phathom Pharmaceuticals Inc (PHAT)’s stock chart: A technical perspective - US Post News
Phathom's Voquezna: A Breakthrough Drug Facing Marketing Challenges (NASDAQ:PHAT) - Seeking Alpha
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) - PR Newswire
Federated Hermes Inc. Cuts Stock Holdings in Hilton Grand Vacations Inc. (NYSE:HGV) - Defense World
Dimensional Fund Advisors LP Grows Stock Position in Koninklijke Philips (NYSE:PHG) - MarketBeat
Rhumbline Advisers Has $710,000 Stock Holdings in Koninklijke Philips (NYSE:PHG) - Defense World
Philips Must Face Investor Suit Over FDA Compliance Issues - Law360
PulteGroup Inc [PHM] Insider FOLLIARD THOMAS J sells 19,000 Shares – Latest News - Knox Daily
Citi resumes HPE stock coverage with Neutral rating and $20 price target - Invezz
What You Didn’t Know About Hewlett Packard Enterprise Co (NYSE: HPE) This Week - Stocks Register
Oracle Investment Management Inc. Invests $2.32 Million in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - MarketBeat
Koninklijke Philips (NYSE:PHG) Shares Bought by Vanguard Personalized Indexing Management LLC - Defense World
Kayne Anderson Rudnick Investment Management LLC Has $443,000 Position in Koninklijke Philips (NYSE:PHG) - Defense World
HashiCorp (NASDAQ:HCP) Receives New Coverage from Analysts at StockNews.com - MarketBeat
Fidelis Capital Partners LLC Sells 155 Shares of Hilton Worldwide Holdings Inc. (NYSE:HLT) - Defense World
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 4% - MarketBeat
Hikma Pharmaceuticals falls Monday, underperforms market - MarketWatch
Investing in Herbalife Ltd (HLF): What You Must Know - Knox Daily
Fairscale Capital LLC Acquires Shares of 2,083 Koninklijke Philips (NYSE:PHG) - Defense World
1,121 Shares in Hilton Worldwide Holdings Inc. (NYSE:HLT) Acquired by Brighton Jones LLC - Defense World
Summit Trail Advisors LLC Has $769,000 Holdings in Koninklijke Philips (NYSE:PHG) - Defense World
Ensign Peak Advisors Inc Has $23.12 Million Stock Holdings in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - MarketBeat
Hancock Whitney Corp Buys 10,920 Shares of PHINIA Inc. (NYSE:PHIN) - MarketBeat
HFCL shares jump 5% on deal to supply critical sub-systems to General Atomics - Moneycontrol
PHINIA Inc. (NYSE:PHIN) Shares Acquired by Long Road Investment Counsel LLC - Defense World
HFCL shares surge over 4% today after forming partnership with General Atomics - Business Upturn
Koninklijke Philips (NYSE:PHG) Stake Raised by Holderness Investments Co. - Defense World
Pfizer Inc. (NYSE:PFE) Shares Sold by Hancock Whitney Corp - Defense World
Herbalife Ltd. (NYSE:HLF) Given Average Rating of “Hold” by Analysts - Defense World
Nkcfo LLC Raises Stock Position in Koninklijke Philips (NYSE:PHG) - Defense World
Huber Capital Management LLC Boosts Stock Position in Herbalife Ltd. (NYSE:HLF) - Defense World
PBF Energy, Valero downgraded at Piper Sandler to reflect near-term headwinds (NYSE:PBF) - Seeking Alpha
Hsbc Holdings PLC Has $74.53 Million Holdings in PPG Industries, Inc. (NYSE:PPG) - Defense World
SYSTM Wealth Solutions LLC Trims Holdings in Koninklijke Philips (NYSE:PHG) - Defense World
Riverview Capital Advisers LLC Takes Position in Koninklijke Philips (NYSE:PHG) - Defense World
Phathom Pharmaceuticals (NASDAQ:PHAT) Reaches New 1-Year High at $19.76 - MarketBeat
Federated Hermes Inc. Has $4.26 Million Holdings in Hilton Worldwide Holdings Inc. (NYSE:HLT) - Defense World
Phathom Pharmaceuticals (NASDAQ:PHAT) Trading 3.9% Higher - MarketBeat
Monitoring Phathom Pharmaceuticals Inc (PHAT) after recent insider movements - Knox Daily
Investors in cash trouble should check out Phathom Pharmaceuticals Inc (PHAT) - SETE News
Phathom Pharmaceuticals Inc (PHAT)’s stock rises to 18.89 per share - US Post News
Phathom Pharmaceuticals Inc (PHAT) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Financial Analysis: Phathom Pharmaceuticals Inc (PHAT)’s Ratios Unveil Key Insights - The Dwinnex
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 1.6% - MarketBeat
Phathom Pharmaceuticals' (PHAT) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Phathom Pharmaceuticals Inc [NASDAQ: PHAT] Sees Increase in Stock Value - Knox Daily
Phathom Pharmaceuticals (NASDAQ:PHAT) Sets New 1-Year High at $18.67 - MarketBeat
Financial Metrics Unveiled: Phathom Pharmaceuticals Inc (PHAT)’s Key Ratios in the Spotlight - The Dwinnex
A History of Outperforming Analyst Forecasts and Beating the Odds: Phathom Pharmaceuticals Inc (PHAT) - SETE News
Phathom Pharmaceuticals Inc Stock (PHAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):